Načítá se...
Topical application of the tumour necrosis factor‐α antibody infliximab improves healing of chronic wounds
The role of tumour necrosis factor‐alpha (TNF‐α) in wound healing is not clear. Elevated levels of TNF‐α have been observed in fluids from chronic wounds and have been shown to decrease over time during the healing process. Therapeutic antibodies such as infliximab can inhibit TNF‐α activity. In thi...
Uloženo v:
| Vydáno v: | Int Wound J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7951247/ https://ncbi.nlm.nih.gov/pubmed/16984574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2006.00233.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|